Skip to content

A Study on ayurveda drugs Shashanklekhadi Churna and Edgajadi Lepa in the treatment of Skin disease

A clinical study to evaluate the efficacy of Shashanklekhadi Churna and Edgajadi Lepa in the management of Mandal Kushtha w.s.r. to Psoariasis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039115
Enrollment
30
Registered
2022-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Madan Mohan Malviya Govt Ayurved College Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing for trial. 2. The patients who ages in between 20 - 70 years were selected. 3. The patients having clinical signs and symptoms of Mandal Kushtha (Psoriasis). 4. The patients having complaints less than 3 years duration

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 20 years and above 70 years. 2. Patients with illness >3 years. 3. Patients with long term Steroid and cytotoxic treatment taking more than 3 years. 4. Patients having concomitant illness like DM, AIDS and other Auto immune disorders. 5. Patients with evidence of any malignancy. 6. Any drug addiction. 7. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Improvement in sign & symptomsTimepoint: 2 months

Secondary

MeasureTime frame
Efficacy of treatmentTimepoint: 2 months

Countries

India

Contacts

Public ContactDr Indumati Sharma

Madan Mohan Malviya Govt. Ayurved College Udaipur

drindusharma4@gmail.com7976972310

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026